[ Back ]   [ More News ]   [ Home ]
Arteris Announces Financial Results for the Fourth Quarter and Full Year 2021 and Estimated First Quarter and Full Year 2022 Guidance

CAMPBELL, Calif., March 03, 2022 (GLOBE NEWSWIRE) -- Arteris, Inc. (Arteris or Arteris IP), a leading provider of network-on-chip (NoC) interconnect and other intellectual property (IP) technology that manages the on-chip communications in system-on-chip (SoC) semiconductor devices, today announced financial results for the fourth quarter and year ended December 31, 2021, and provided estimated first quarter and full year 2022 guidance.

"We’re excited to see our momentum continue in the fourth quarter, with our total number of Active Customers increasing from 179 to 192 across a broad base of applications including Machine Learning, Automotive and 5G,” said K. Charles Janac, President and CEO of Arteris IP. “As we look ahead we believe there are a number of tailwinds that help our business including the increase in SoC complexity making it increasingly difficult for our customers to develop system IP solutions in house, and the increasing number of IP blocks in SoC designs also increasing the value of IPD IP deployment software solutions. As a result, we are seeing a trend toward SoC system IP solutions being increasingly licensed from industry leading commercial vendors like Arteris IP."

Fourth Quarter 2021 Financial Highlights:

Full year 2021 Financial Highlights:

Fourth Quarter 2021 Business Highlights:

Estimated First Quarter and Full Year 2022 Guidance:

  Q1 2022FY 2022
  (in millions, except %)
 ACV + TTM royalties$50.5 - $52.5$51.6 - $55.6
 Revenue$10.0 - $12.0$47.0 - $51.0
 Non-GAAP operating loss (%)41.1% - 56.1%25.6% - 40.6%
 Free cash flow (%)(38.0)% - (23.0)%(25.9)% - (10.9)%

The guidance provided above are forward-looking statements and reflect our expectations as of today's date. Actual results may differ materially. Refer to the "Forward-Looking Statements" below for information on the factors, among others, that could cause our actual results to differ materially from these forward-looking statements.

Non-GAAP operating income (loss), non-GAAP operating income (loss) margin, non-GAAP net income (loss), non-GAAP net income (loss) per share, non-GAAP free cash flow and non-GAAP free cash flow margin are non-GAAP financial measures. Additional information on Arteris’ historic reported results, including a reconciliation of these non-GAAP financial measures to their most comparable GAAP measures, is included in the financial tables below. A reconciliation of non-GAAP guidance measures reported above to corresponding GAAP measures is not available on a forward-looking basis without unreasonable effort due to the uncertainty of expenses that may be incurred in the future, although it is important to note that these factors could be material to Arteris’ results computed in accordance with GAAP.

Definitions of the other business metrics used in this press release including ACV, Active Customers and Customer Retention, Design Starts and RPO are included below under the heading “Other Business Metrics.”

Conference Call

Arteris will host a conference call today on March 3, 2022 to review its fourth quarter and full year 2021 financial results and to discuss its financial outlook.

 Time:4:30PM ET 
 United States/Canada Toll Free:877-407-9208 
 International Toll:1-201-493-6784 
 Conference ID:13726720 

A live webcast will also be available in the Investor Relations section of Arteris’ website at: https://ir.arteris.com/events-and-presentations

A replay of the webcast will be available in the Investor Relations section of the company’s web site approximately two hours after the conclusion of the call and remain available for approximately 30 calendar days.

About Arteris

Arteris IP (Nasdaq: AIP) provides system-on-chip (SoC) system IP consisting of network-on-chip (NoC) interconnect IP and IP deployment technology to accelerate system-on-chip (SoC) semiconductor development and integration for a wide range of applications from AI to automobiles, mobile phones, IoT, cameras, SSD controllers, and servers for customers such as Bosch, Mobileye, Samsung, Toshiba and NXP. Arteris IP products include the Ncore® cache coherent and FlexNoC® non-coherent interconnect IP, the CodaCache® standalone last level cache, and optional Resilience Package (ISO 26262 functional safety), FlexNoC AI Package, and PIANO® automated timing closure capabilities. Our IP deployment products provide intelligent automation that accelerates the development and increases the quality of SoC hardware designs and their associated software and firmware, verification and simulation platforms, and specifications and customer documentation. Customer results obtained by using Arteris IP products include lower power, higher performance, more efficient design reuse and faster SoC development, leading to lower development and production costs. For more information, visit www.arteris.com or find us on LinkedIn at https://www.linkedin.com/company/arteris.

Investor Contacts:
Arteris
Nick Hawkins
Chief Financial Officer
IR@arteris.com

Sapphire Investor Relations
Erica Mannion and Michael Funari
+1 617 542 6180
IR@arteris.com

Forward-Looking Statements

This press release contains forward-looking statements, including but not limited to, statements regarding our future financial and operating performance, including our GAAP and non-GAAP guidance for the first quarter and full year 2022 and our market opportunity and its potential growth, as well as our position within the market. Any forward-looking statements contained herein are based on our historical performance and our current plans, estimates and expectations and are not a representation that such plans, estimates, or expectations will be achieved. These forward-looks statements represent our expectations as of the date of this press release. Subsequent events may cause these expectations to change, and we disclaim any obligation to update the forward-looking statements in the future, except as required by law. These forward-looking statements are subject to known and unknown risks and uncertainties that may cause actual results to differ materially from our current expectations. Important factors that could cause actual results to differ materially from those anticipated in our forward-looking statements include, but are not limited to, the significant competition we face from larger companies and third-party providers; our history of net losses; whether semiconductor companies in the automotive market, AI/ML market, 5G and wireless communications market, large scale cloud and data center market and consumer electronics market incorporate our solutions into their end products; our ability to attract new customers and the extent to which our customers renew their subscriptions for our solutions; the ability of our customers’ end products achieving market acceptance or growth; our ability to sustain or grow our licensing revenue; our ability, and the cost, to successfully execute on research and development efforts; the occurrence of product errors or defects in our solutions; if we fail to offer high-quality support; the occurrence of macro-economic conditions that adversely impact us, our customers and their end product markets; the range of regulatory, operational, financial and political risks we are exposed to as a result of our dependence on international customers and operations; our ability to protect our proprietary technology and inventions through patents and other IP rights; whether we are subject to any liabilities or fines as a result of government regulation, including import, export and economic sanctions laws and regulations; the occurrence of a disruption in our networks or a security breach; risks associated with doing business in China; and the other factors described under the heading “Risk Factors” in our Annual Report on Form 10-K for the year ended December 31, 2021 to be filed with the Securities and Exchange Commission (SEC) on or about the date hereof and our subsequent filings with the SEC. All forward-looking statements reflect our beliefs and assumptions only as of the date of this press release. We undertake no obligation to update forward-looking statements to reflect future events or circumstances. Our results for the quarter ended December 31, 2021 are not necessarily indicative of our operating results for any future periods.


Arteris, Inc
Condensed Consolidated Statements of Loss and Comprehensive Loss
(in thousands, except share and per share data)
(Unaudited)

 Three Months Ended December 31, Twelve Months Ended December 31,
  2021   2020   2021   2020 
Revenue       
Licensing, support and maintenance$10,378  $13,403  $34,731  $27,408 
Variable royalties and other 1,056   1,043   3,133   4,404 
Total revenue 11,434   14,446   37,864   31,812 
Cost of revenue 1,113   373   3,731   1,491 
Gross profit 10,321   14,073   34,133   30,321 
Operating expense:       
Research and development 10,240   5,178   30,812   17,020 
Sales and marketing 3,755   3,404   11,726   9,749 
General and administrative 3,606   2,336   13,360   7,329 
Total operating expenses 17,601   10,918   55,898   34,098 
(Loss) income from operations (7,280)  3,155   (21,765)  (3,777)
Gain on extinguishment of debt    1,593   10   1,593 
Interest and other expense, net (82)  61   (589)  (50)
(Loss) income before provision for income taxes (7,362)  4,809   (22,344)  (2,234)
Provision (benefit) for income taxes 428   (2,767)  1,040   1,026 
Net (loss) income (7,790)  7,576   (23,384)  (3,260)
Less: Net income attributable to participating securities    (1,520)      
Net (loss) income attributable to common stockholders$(7,790) $6,056  $(23,384) $(3,260)
        
Net (loss) income per share attributable to common stockholders:       
Basic$(0.27) $0.34  $(1.06) $(0.19)
Diluted$(0.27) $0.29  $(1.06) $(0.19)
        
Weighted average shares used on computing per share amounts:       
Basic 28,501,707   17,823,657   21,972,101   17,577,846 
Diluted 28,501,707   20,546,017   21,972,101   17,577,846 


Arteris, Inc.
Condensed Consolidated Balance Sheets
(In thousands, except share and per share data)
(unaudited)

 As of
 December 31, 2021 December 31, 2020
ASSETS    
Currents assets:   
Cash$85,825  $11,744 
Accounts receivable, net 13,873   14,350 
Prepaid expenses and other current assets 6,949   2,858 
Total current assets 106,647   28,952 
Property and equipment, net 2,438   2,365 
Operating lease right-of-used assets 2,765   2,753 
Intangibles, net 2,959   3,409 
Goodwill 2,677   2,677 
Other assets 2,957   2,580 
TOTAL ASSETS$120,443  $42,736 
LIABILITIES, REDEEMABLE CONVERTIBLE PREFERRED STOCK AND STOCKHOLDERS' DEFICIT    
Current liabilities:   
Account payable$1,722  $1,116 
Accrued expenses and other current liabilities 10,573   7,249 
Operating lease liabilities, current 961   767 
Deferred revenue, current 28,403   17,894 
Vendor financing arrangements, current 833   643 
Term loan    557 
Total current liabilities 42,492   28,226 
Deferred revenue, noncurrent 20,773   15,014 
Operating lease liabilities, noncurrent 1,851   2,079 
Vendor financing arrangements, noncurrent 266   727 
Other liabilities 2,157   2,986 
Total liabilities 67,539   49,032 
Redeemable convertible preferred stock:   
Redeemable convertible preferred stock, par value of $0.001, no shares authorized, issued, and outstanding at December 31, 2021; 4,471,316 shares authorized, issued and outstanding at December 31, 2020 (aggregate liquidation preference of zero and $5,768 at December 31, 2021 and 2020, respectively)    5,712 
Stockholders' equity (deficit):   
Preferred stock, par value of $0.001—10,000,000 and no shares authorized at December 31, 2021 and 2020, respectively; no shares issued and outstanding at December 31, 2021 and 2020     
Common stock, par value of $0.001—300,000,000 and 31,525,154 shares authorized at December 31, 2021 and 2020, respectively; 31,530,682 and 18,486,989 shares issued and outstanding at December 31, 2021 and 2020, respectively 31   18 
Additional paid-in-capital 91,945   3,612 
Accumulated other comprehensive loss (81)  (31)
Accumulated deficit (38,991)  (15,607)
Total stockholders' equity (deficit) 52,904   (12,008)
TOTAL LIABILITIES REDEEMABLE CONVERTIBLE PREFERRED STOCK AND STOCKHOLDERS' EQUITY (DEFICIT)$120,443  $42,736 


Arteris, Inc.
Condensed Consolidated Statements of Cash Flows
(In thousands)
(unaudited)

  Twelve Months Ended December 31,
   2021   2020 
CASH FLOWS FROM OPERATING ACTIVITIES:    
Net loss $(23,384) $(3,260)
Adjustments to reconcile net loss to net cash (used in) provided by operating activities:    
Depreciation and amortization  1,492   935 
Stock-based compensation  5,510   458 
Pension plan expenses  109   33 
Operating non-cash lease expense  (12)  532 
Gain on extinguishment of debt  (10)  (1,593)
Other  1   1 
Changes in operating assets and liabilities:    
Accounts receivable, net  477   (6,324)
Prepaid expenses and other assets  (4,418)  (2,608)
Accounts payable  350   414 
Accrued expenses and other liabilities  2,836   3,016 
Operating lease liabilities  (33)  (527)
Deferred revenue  16,268   11,086 
Net cash (used in) provided by operating activities  (814)  2,163 
CASH FLOWS FROM INVESTING ACTIVITIES:    
Purchases of property and equipment  (808)  (654)
Payments for business acquisition     (4,500)
Payments of deferred consideration for business acquisition  (500)   
Other  (51)  7 
Net cash used in investing activities  (1,359)  (5,147)
CASH FLOWS FROM FINANCING ACTIVITIES:    
Proceeds from issuance of common stock upon initial public offering, net of underwriting commissions and other issuance costs  71,344    
Proceeds from issuance of common stock  5,435    
Proceeds from PPP Loan     1,603 
Payments of principal portion of Term loan  (550)  (600)
Principal payments under vendor financing arrangements  (574)  (441)
Proceeds from exercise of stock options  599   236 
Other     (8)
Net cash provided by financing activities  76,254   790 
NET INCREASE (DECREASE) IN CASH  74,081   (2,194)
CASH, beginning of period  11,744   13,938 
CASH, end of period $85,825  $11,744 
     

Non-GAAP Financial Measures

To supplement our financial results, which are prepared and presented in accordance with GAAP, we use certain non-GAAP financial measures, as described below, to understand and evaluate our core performance. These non-GAAP measures, which may be different than similarly-titled measures used by other companies, are presented to enhance investors’ overall understanding of our financial performance and should not be considered a substitute for, or superior to, the financial information prepared and presented in accordance with GAAP.

We define “Non-GAAP Income (Loss) from Operations” as our income (loss) from operations adjusted to exclude stock-based compensation, acquisition costs and amortization of acquired intangible assets. We define “Non-GAAP Net Loss” as our net income (loss) adjusted to exclude stock-based compensation, acquisition costs, amortization of acquired intangible assets and gain on extinguishment of debt.

We define “Non-GAAP EPS”, as our Non-GAAP Net Income (Loss) divided by our GAAP weighted-average number of shares outstanding for the period on a diluted basis. Management uses Non-GAAP EPS to evaluate the performance of our business on a comparable basis from period to period.

The above items are excluded from our Non-GAAP Income (Loss) from Operations and Non-GAAP Net Income (Loss) because these items are non-cash in nature, or are not indicative of our core operating performance, and render comparisons with prior periods and competitors less meaningful. We believe Non-GAAP Income (Loss) from Operations, Non-GAAP Net Income (Loss) provide useful supplemental information to investors and others in understanding and evaluating our results of operations, as well as provide a useful measure for period-to-period comparisons of our business performance.

We define free cash flow as net cash provided by operating activities less cash used for purchases of property and equipment. We believe that free cash flow is a useful indicator of liquidity that provides information to management and investors, even if negative, about the amount of cash used in our operations other than that used for investments in property and equipment.

Other Business Metrics

Annual Contract Value (ACV) – we define Annual Contract Value for an individual customer agreement as the total fixed fees under the agreement divided by the number of years in the agreement term. Our total ACV is the aggregate ACVs for all our customers as measured at a given point in time. Total fixed fees includes licensing, support and maintenance and other fixed fees under IP licensing or software licensing agreements but excludes variable revenue derived from licensing agreements with customers, particularly royalties. We monitor ACV to measure our success and believe the increase in the number shows our progress in expanding our customers’ adoption of our solutions.

Active Customers and Customer Retention – we define Active Customers as customers who have entered into a license agreement with us that remains in effect. The retention and expansion of our relationships with existing customers are key indicators of our revenue potential.

Design Starts – we define Design Starts as when customers commence new semiconductor designs using our interconnect IP and notify us. Design Starts is a metric management uses to assess the activity level of our customers in terms of the number of new semiconductor designs that are started using our interconnect IP in a given period. We believe that the number of Design Starts is an important indicator of the growth of our business and future royalty revenue trends.

Remaining Performance Obligations (RPO) – we define Remaining Performance Obligations as the amount of contracted future revenue that has not yet been recognized, including both deferred revenue and contracted amounts that will be invoiced and recognized as revenue in future periods.


Arteris, Inc.
Reconciliation of GAAP Measures to Non-GAAP Measures
(In thousands, except share and per share data)
(unaudited)

Non-GAAP (Loss) Income from Operations

 Three Months Ended December 31, Twelve Months Ended December 31,
  2021   2020  2021   2020 
 (in thousands)
(Loss) income from operations$(7,280) $3,155 $(21,765) $(3,777)
Add:       
Stock-based compensation expense (1) 4,366   177  5,510   458 
Acquisition costs (2)    1,429  238   1,429 
Amortization of acquired intangible assets (3,4) 120   41  478   41 
Non-GAAP (loss) income from operations$(2,794) $4,802 $(15,539) $(1,849)

(1) Includes stock-based compensation expense as follows:

 Three Months Ended December 31, Twelve Months Ended December 31,
  2021  2020  2021  2020
 (in thousands)
Research and development$2,850 $105 $3,495 $263
Sales and marketing 683  26  797  92
General and administrative 833  46  1,218  103
Total stock-based compensation expense$4,366 $177 $5,510 $458

(2) Includes advisory, legal, accounting, valuation, and other professional or consulting fees associated with the Magillem acquisition.
(3) Represents the amortization expenses of our intangible assets attributable to the Magillem acquisition.
(4) Includes amortization of acquired intangible assets as follows:

 Three Months Ended December 31, Twelve Months Ended December 31,
  2021  2020  2021  2020
 (in thousands)
Research and development$85 $29 $340 $29
Sales and marketing 35  12  138  12
Total amortization$120 $41 $478 $41

Non-GAAP Net (Loss) Income and Non-GAAP EPS, Basic and Diluted

 Three Months Ended December 31, Twelve Months Ended December 31,
  2021   2020   2021   2020 
 (in thousands, excepts per share data)
Net (loss) income$(7,790) $6,056  $(23,384) $(3,260)
Add:       
Stock-based compensation expense (1) 4,366   177   5,510   458 
Acquisition costs (2)    1,429   238   1,429 
Amortization of acquired intangible assets (3,4) 120   41   478   41 
Gain on extinguishment of debt    (1,593)  (10)  (1,593)
Non-GAAP net (loss) income (5)$(3,304) $6,110  $(17,168) $(2,925)
        
Net (loss) income per share attributable to common stockholders, basic$(0.27) $0.34  $(1.06) $(0.19)
Net (loss) income per share attributable to common stockholders, diluted$(0.27) $0.29  $(1.06) $(0.19)
Per share impacts of adjustments to net (loss) income (6)$0.15  $  $0.28  $0.02 
Non-GAAP EPS, basic$(0.12) $0.34  $(0.78) $(0.17)
Non-GAAP EPS, diluted$(0.12) $0.29  $(0.78) $(0.17)
        
Weighted average shares used in computing per share amounts, basic 28,501,707   17,823,657   21,972,101   17,577,846 
Weighted average shares used in computing per share amounts, diluted 28,501,707   20,546,017   21,972,101   17,577,846 

(1) See table in footnote (1) to the Non-GAAP (Loss) Income from Operations above for breakdown of stock-based compensation expense by line item.
(2) Includes advisory, legal, accounting, valuation, and other professional or consulting fees associated with the Magillem acquisition.
(3) Represents the amortization expenses of our intangible assets attributable to the Magillem acquisition.
(4) See table in footnote (4) to the Non-GAAP (Loss) Income from Operations above for breakdown of amortization of acquired intangible assets by line item.
(5) Our GAAP tax provision is primarily related to foreign withholding taxes and income tax in profitable foreign jurisdictions. We maintain a full valuation allowance against our deferred tax assets in the US. Accordingly, there is no significant tax impact associated with these non-GAAP adjustments.
(6) Reflects the aggregate adjustments made to reconcile Non-GAAP Net (Loss) Income to our net loss as noted in the above table, divided by the GAAP diluted weighted average number of shares of the relevant period.


Free Cash Flow

 Three Months Ended December 31, Twelve Months Ended December 31,
  2021   2020   2021   2020 
 (in thousands)
Net cash provided by (used in) operating activities$3,192  $2,665  $(814) $2,163 
Less:       
Purchase of property and equipment (320)  (131)  (808)  (654)
Free cash flow$2,872  $2,534  $(1,622) $1,509 
Net cash used in investing activities$(871) $(4,624) $(1,359) $(5,147)
Net cash provided by (used in) financing activities$72,263  $(149) $76,254  $790 

Primary Logo